與國際級企業、潛力新創公司、台灣創新創業中心（TIEC）及Taiwan Tech Arena（TTA）補助之新創公司等合作，研習學員進入國際企業研習，共同參與產業技術研發、產品設計、商業發展或新創實務工作。
英文能力證明：檢附107年12月以後之英文能力證明文件尤佳( 多益750分以上或同等級之其他官方檢定結果) 。
Applied Materials is a world-wide largest Semiconductor and Display equipment manufacturer.
Apeximmune Therapeutics seeks to harness the power of the immune system to treat and cure cancer. We discover and pioneer innovative therapeutic antibodies against novel targets to modulate immune cell activity and elicit durable efficacy in cancer. Apeximmune’s target discovery platform combines bioinformatics with biological assays to enable identification of novel immune modulating targets. Currently, antibodies for three immuno-oncology target programs in the pre-clinical stage are being actively developed with the goal of reaching IND status within 18 months.
BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support.
Our product expertise covers a diverse set of research areas including Immunology, Neuroscience, Cancer, Stem cells, and Cell Biology. BioLegend's reagents are supported by superior customer service and a quality management system that is certified for ISO 13485:2016. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including:
Flow cytometry and mass cytometry
ELISA and ELISPOT
Immunoprecipitation and ChIP
In vitro or in vivo functional assays.
BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers' specific needs.
Our commitment to the research community is reflected in generous sponsorships of societies and meetings world-wide, our monthly travel award for junior investigators, and excellent bulk pricing. With iPhone/iPad apps, web tools, beautifully detailed posters, and new reagents, we look forward to bringing more creative innovation to make your research legendary.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Kyocera International Inc. is a subsidiary of Kyocera Corporation. Kyocera International Inc. conducts business in multiple areas (Semiconductor Components, Communication Equipment Group, Fine Ceramics Group, Optical Division, Consumer Product Division, Display Division, Automotive Components). The division which will participate in LEAP activity has been developing mmWave phased-array antenna for past 30 years. The division is actively developing RFIC, microwave package, phased-array antenna for 5G cellular and Satellite market.
LIGHTEL is an advanced technology company located in the Greater Seattle to service the Fiber Optics & Photonics industries worldwide. The new focus is to develop Hi-power (KW) technologies for
Fiber Laser applications to serve the Industry 4.0., IMS (Intelligent Manufacturing System) and
NVIDIA’s invention of the GPU sparked the PC gaming market. The company’s pioneering work in accelerated computing—a supercharged form of computing at the intersection of computer graphics, high performance computing and AI—is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others.
PARTNERS AND COLLABORATORS
Omega Optics, Inc. is a leading company started in Austin, Texas in 2001. Since its initiation, Omega Optics has been actively involved in optical communications/sensing field where arrays of products have been developed from internal R&D and SBIR/STTR efforts. Technologies including portable bio-sensing, polymer based planar light wave circuit for EM-wave sensing, chemical and biological sensing , and nanophotonics for integrated photonic circuits, are core technologies. Omega Optics, with its vast experience in SBIR/STTR programs, is in a vantage position to pursue this aggressive commercialization strategy. Omega’s scientists and engineers have research project experience with partners and sponsors such as General Electric, Cray Research, Honeywell, 3M, Dell, Lightpath, Boeing, Physical Optics Corp., Novex Corp., Lambda Physik USA. The management team has a commercialization track record of raising $18 million venture capital investment SBIR phase II matching funds in 2000 from Intel venture, KLM venture which was later acquired by Finisar, a publicly traded company, in 2001.
Founded in 2018, PETcoil was formed by a group of imaging scientists, engineers, and radiologists aspired to improve healthcare by creating novel medical imaging technology and bringing it to millions of patients around the globe. Our team has its roots at Stanford University, where our founders created their first-ever radiofrequency-penetrable PET insert system for simultaneous PET and MRI imaging.
Our vision is to make multi-modality medical imaging accessible to every patient. Our mission is to create affordable, high-performance molecular imaging systems to drive early and accurate diagnosis of diseases.
(Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines.
Taboola helps people find relevant content online, matching them with news stories, articles, blogs, videos, apps, products and other content they’re likely to want to explore.
How do we know what they’ll like? Using machine-learning algorithms, our technology analyzes hundreds of signals to capture exactly what kind of content is most likely to engage each individual. We do that more than 450 billion times a month for more than one billion unique users.
Since we opened our doors in 2006, we have grown to become the leading discovery platform on the open web, serving a combination of the world’s best brands and the most respected global publishers.
Taboola is headquartered in New York City with local offices in Los Angeles, London, Tel Aviv, New Delhi, Bangkok, São Paulo, Beijing, Shanghai, Istanbul, Seoul, Sydney and Tokyo.
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry.
Tubis Technology Inc. has been developing mmWave phased-array antenna for 5G cellular and Satellite market for the past 6 years. The area of focus and expertise is Semiconductor Design – Advanced CMOS and GaAs, Packaging Technology – antenna in package and silicon in package, RF systems technology – RF IC design, phased-array technology, beam forming
By designing wearable devices in new ways, Wearifi is a technology company seeking to create epidermal electronics with all of the performance of the current state of the art at a fraction of the size. Our mission is to devise the next generation of electronic solutions – integrated, invisible when you want them to be, and battery-free – to personal healthcare that promote positive feedback between cognitive science and precision medicine.
Wearifi has partnered with multiple Fortune 500 companies, the Department of Health and Human Services, and leading research hospitals to drive personalized healthcare management with wearable electronic gadgets. The core technology represents not only the outcome of research efforts from Querrey Simpson Institute for Bioelectronics at Northwestern University but continuous interactions with the research/clinical teams to develop engineering solutions that are capable of non-invasively skin health monitoring, motion envelope visualization, haptic feedback for VR/AR and prosthetic applications, in-real time. At Wearifi, you’ll have an opportunity to work in a collaborative environment that leads to academic publications and technology innovations, so together we can engineer the future of smart healthcare.